Gene · 2596
Papers3,821
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,821
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Schwann Cell Expression Pattern in Human Melanomas: In Silico and Immunohistochemical Analyses. | Int J Mol Sci | 2026 | 42794688 | PubTator, text mining | PubMed |
| [Laryngeal squamous cell carcinoma-derived exosomes promote neuronal axonal growth by remodeling the neural microenvironment]. | Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2026 | 42706064 | PubTator, text mining | PubMed |
| Non-invasive radiogenomic assessment of growth-associated protein 43 in lung adenocarcinoma brain metastases. | Eur J Radiol | 2026 | 42648196 | PubTator, text mining | PubMed |
| Decreased cerebrospinal fluid NDRG2 is associated with non-Alzheimer's disease derived mild cognitive impairment. | J Alzheimers Dis | 2026 | 42593291 | PubTator, text mining | PubMed |
| Painful neuromas exhibit axonal phenotypic shift via nociceptive and mechanosensitive marker up-regulation. | PNAS Nexus | 2026 | 42582843 | PubTator, text mining | PubMed |
| Actin, connexin-43 and GAP-43 expression in gliomas: real-world associations with IDH status, tumor burden and survival. | J Neurooncol | 2026 | 42570146 | PubTator, text mining | PubMed |
| Elevated CSF GAP-43 is associated with reduced cerebral glucose metabolism and cognitive impairment in individuals with mild cognitive impairment. | Brain Imaging Behav | 2026 | 42489996 | PubTator, text mining | PubMed |
| Higher physical activity levels mitigate synaptic protein loss and cognitive deterioration in aging and in Alzheimer's disease: a 10-year longitudinal study. | Mol Biomed | 2026 | 42455424 | PubTator, text mining | PubMed |
| Aquaporin-4 Localization in Terminal Glial Cells of Human Mechanosensory Corpuscles: An Immunohistochemical Study of Penile Tissues. | J Histochem Cytochem | 2026 | 42394629 | PubTator, text mining | PubMed |
| APOE ε4-specific associations between agitation, cerebrospinal fluid biomarkers, and cognitive decline in cognitively impaired patients. | J Alzheimers Dis | 2026 | 42377429 | PubTator, text mining | PubMed |
| Impact of per- and polyfluoroalkyl substances (PFAS) on brain development and function. | Behav Brain Res | 2026 | 42361859 | PubTator, text mining | PubMed |
| A Polydopamine-coated Engineered Type II Collagen Scaffold for Motor Neuron Organization and Spinal Cord Injury Regeneration. | Biomater Adv | 2026 | 42287938 | PubTator, text mining | PubMed |
| Translational potential of GMP-grade human umbilical cord-derived mesenchymal stem cells (UC-MSCs) in traumatic spinal cord injury: a preclinical study in rat. | J Transl Med | 2026 | 42271443 | PubTator, text mining | PubMed |
| Identification and validation of growth hormone-reactive gene markers in brain tissue during the recovery period of stroke. | Brain Res Bull | 2026 | 42248536 | PubTator, text mining | PubMed |
| Injectable sericin/gelatin hydrogel enables sustained BDNF delivery and promotes neural repair under hemorrhagic injury conditions. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42234118 | PubTator, text mining | PubMed |
| 3'UTR regulation of axon translation and optic nerve regeneration. | Mol Neurodegener | 2026 | 42216210 | PubTator, text mining | PubMed |
| Synaptic biomarkers in Alzheimer's disease dementia and mild cognitive impairment: A systematic review and meta-analysis. | Alzheimers Dement | 2026 | 42192211 | PubTator, text mining | PubMed |
| Nyap1 Redirects JNK Signaling to Couple Neuroprotection with Circuit Regeneration After Spinal Cord Injury. | Cell Mol Neurobiol | 2026 | 42176223 | PubTator, text mining | PubMed |
| Molecular Insights into the Neurogenic Potential of Alpha-lipoic Acid. | Curr Top Med Chem | 2026 | 42152711 | PubTator, text mining | PubMed |
| Modeling Synaptic Maturation From Growth Cone to Synapse in Human Organoids. | J Neurochem | 2026 | 42108706 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2596/papers